5.60
+0.06
+(1.08%)
At close: January 31 at 4:14:27 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.3M | 22.6M |
| Low Estimate | -- | -- | 6.3M | 22.6M |
| High Estimate | -- | -- | 6.3M | 22.6M |
| Year Ago Sales | -- | -- | 3.99M | 6.3M |
| Sales Growth (year/est) | -- | -- | 57.86% | 258.73% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LYTIX.OL | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Related Tickers
PCIB.OL PCI Biotech Holding ASA
1.2500
+2.12%
CRNA.OL Circio Holding ASA
0.6580
+1.23%
ABTEC.OL Aqua Bio Technology ASA
3.2400
+3.18%
PEG.CO Pharma Equity Group A/S
0.1590
+1.27%
BINV.ST BioInvent International AB (publ)
28.60
+5.73%
FLUI.ST Fluicell AB (publ)
0.0576
+3.60%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
BGBIO.OL BerGenBio ASA
7.90
-1.04%
FLUO.ST FluoGuide A/S
50.10
+1.11%
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%